Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
Vaccine efficacy against primary CMV infection ranged from 6 per cent to 23 per cent, depending on case definition, falling short of Moderna’s predefined target
The combination is approved for advanced endometrial carcinoma that is pMMR or not MSI-H and has progressed after prior systemic therapy
Lutavit A/D3 1000/200 NXT provides a combination of vitamin A and vitamin D3 in one formulation
These findings follow positive Phase 3 results presented earlier this year
New test expands access to early Alzheimer’s assessment, streamlining diagnostic pathways and improving referral efficiency
SkinMedica redefines luxury skincare with reimagined packaging and new HA5 hydra collagen water burst moisturizer
BPDCN is a challenging blood cancer with characteristics of both leukemia and lymphoma
The platform integrates artificial intelligence into a unified environment that supports optical, microCT, ultrasound, and other imaging modalities
The company has received approval from DCGI to begin patient enrolment and dosing in the country
Subscribe To Our Newsletter & Stay Updated
